RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244

Benzinga Newsdesk www.benzinga.com Positive 87.4%

Neg 0% Neu 0% Pos 87.4%

RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $234 to $244.